General Information of the Compound
Compound ID |
CP0209727
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
SOPHORAFLAVANONE B
Show/Hide
|
||||||||||||||||||
Synonyms |
(-)-(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one
(-)-(2S)-8-dimethylallylnaringenin
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4H-chromen-4-one
(S)-8-dimethylallylnaringenin
(s)-8-prenylnaringenin
53846-50-7
5L872SZR8X
8-Prenylnaringenin
8-dimethylallylnaringenin
8-prenylnaringenin (8-PN)
AC1LA3DM
BDBM19460
BIDD:ER0149
CHEBI:50207
CHEMBL376915
CTK5J8800
Flavaprenin
SCHEMBL1171435
SOPHORAFLAVANONE B
Sophoraflavanone B
UNII-5L872SZR8X
YS04
ZINC39452
cid_509245
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H20O5
|
||||||||||||||||||
Molecular Weight |
340.375
|
||||||||||||||||||
Canonical SMILES |
CC(C)=CCc1c(O)cc(O)c2C(=O)CC(Oc12)c1ccc(O)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H20O5/c1-11(2)3-8-14-15(22)9-16(23)19-17(24)10-18(25-20(14)19)12-4-6-13(21)7-5-12/h3-7,9,18,21-23H,8,10H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
LPEPZZAVFJPLNZ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound